MTOR and metabolic dysfunction-associated steatotic liver disease: NAFLD is considered a new major risk factor for HCC, and the increase in serum BCAA levels in NAFLD patients affects glucose metabolism through mTOR signaling (Chalasani et al., 2018; Gaggini et al., 2018; Chakravarthy and Neuschwander-Tetri, 2020).